Phenotyping of -acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?

Alexander Jetter (1, 2) , Martina Kinzig (3) , Michael Rodamer (3) , Dorota Tomalik-Scharte (1) , Fritz Sörgel (3, 4) , Uwe Fuhr (1)

1 Department of Pharmacology, Clinical Pharmacology
2 Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine
3 Institute for Biomedical and Pharmaceutical Research
4 Department of Pharmacology

Mots clés: -acetyltransferase 2; Xanthine oxidase; Phenotyping; Caffeine; Intra-individual variability

Alexander Jetter, Martina Kinzig, Michael Rodamer, Dorota Tomalik-Scharte, Fritz Sörgel, et al.. Phenotyping of -acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?. European Journal of Clinical Pharmacology, 2008, 65 (4), pp.411-417. ⟨10.1007/s00228-008-0597-0⟩. ⟨hal-00534933⟩